GLSI News and Press, Greenwich LifeSciences Inc. From 04/14/21

The GP2 Phase III clinical trial design was presented in a poster during the 2021 American Association for Cancer Research (AACR) Annual Meeting, introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi of Baylor College of Medicine. The Company plans to comp...

Shares of Greenwich LifeSciences (NASDAQ: GLSI) were tanking 27.8% as of 3:34 p.m. EDT on Monday. The huge drop came after the company published a poster over the weekend at the American Association for Cancer Research (AACR) Annual Meeting showing five-year immune response data fro...

Gainers: Wilhelmina International (WHLM) +44%.180 Life Sciences (ATNF) +28%.Evelo Biosciences (EVLO) +24%.Celcuity (CELC) +19%.Taysha Gene Therapies (TSHA) +17%.Nuance Communications (NUAN) +16%.Tiziana Life Sciences (TLSA) +15%.PLBY Group (PLBY) +13%.Pintec Technology (PT) +13%.Aur...

Gainers: Evelo Biosciences (EVLO) +26%, Ikena Oncology (IKNA) 21%, Taysha Gene Therapies (TSHA) +19%, 180 Life Sciences (ATNF) +16%, Tiziana Life Sciences (TLSA) +14%.Losers: iRhythm Technologies (IRTC) -38%, Biophytis (BPTS) -25%, Greenw...

iRhythm Technologies (IRTC) -30% after Novitas publishes updated reimbursement rates.Qualigen Therapeutics (QLGN) -18% after it pulls marketing application for COVID-19 test.Gulf Resources (GURE) -11% on correcting and replacing - Q4 & FY2020 financial result...

Poster published on April 10th at the 2021 American Association for Cancer Research (AACR) Annual Meeting shows the GP2 final 5 year immune response data from the Phase IIb clinical trial, concluding that GP2 immunotherapy generated GP2-specific immune responses leading to promising c...

Poster published today at the 2021 American Association for Cancer Research (AACR) Annual Meeting shows the GP2 final 5 year immune response data from the Phase IIb clinical trial, concluding that GP2 immunotherapy generated GP2-specific immune responses leading to promising clinical ...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks rallied to close at record levels Friday, with the Dow Jones hitting 33,800 and the S&P 500 topping 4,100, as investors ignored co...

Could These Biotech Stocks Be The Best Stocks To Invest In Right Now? You can’t deny that biotech stocks have and continue to receive a whole lot of attention from investors now. Accordingly, this is because of the current pandemic where biotech companies are continuously...

Shares of Greenwich LifeSciences (NASDAQ: GLSI) were rising 4.3% higher as of 11:41 a.m. EDT on Friday after soaring as much as 38.2% earlier in the day. The gain came following the company's announcement of positive results from a phase 2b study evaluating immunotherapy GP2 in trea...